The effect of Am-80, one of retinoids derivatives on experimental allergic encephalomyelitis in rats

Life Sciences

Volumn 67, Issue 15, 2000, Pages 1869-1879

  Wang, Ting ^a   Niwa, Satoru ^a   Bouda, Keiko ^a   Matsuura, Satoko ^a   Homma, Takeyasu ^a   Shudo, Koichi ^b   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Am 80; Experimental allergic encephalomyelitis; Interleukin 6; Retinoid

Indexed keywords

BENZOIC ACID DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 6; MESSENGER RNA; MYELIN BASIC PROTEIN; PREDNISOLONE; RETINOID; TAMIBAROTENE; TETRALIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DOSE RESPONSE; EXTERNAL EAR; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; RAT; RECURRENT DISEASE; SPINAL CORD;

ADMINISTRATION, ORAL; ANIMALS; BENZOATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, EXTERNAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-6; MYELIN BASIC PROTEINS; PREDNISOLONE; RATS; RECURRENCE; RETINOIDS; RNA, MESSENGER; SPINAL CORD; TETRAHYDRONAPHTHALENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034263802     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00776-1     Document Type: Article

References (22)

1. Levine S. A relapsing form of allergic encephalomyelitis in rats due to enhanced absorption of inoculum. Journal of Neuropathology and Experimental Neurology 1986; 45: 247-257.
2. Sedguick J, Brostoff S, Masson DW. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction: severe paralytic disease correlates with the presence of IL-2 receptor positive cells inflitrating the CNS. Journal of Experimental Medicine 1987; 165: 1058-1075.
3. 1+2- lymphocytes. The Journal of Immunology 1981; 127: 1420-1423.
4. Alvord EC, Kies MW, Suckling AJ. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. In Alan R, editor. New York Liss, Inc., 1995.
5. Nagai H, Goto M, Kamada H, Boda K, Kitagaki K, Takaoka Y. Immunopharmacological studies on experimental allergic encephalomyelitis in DA rats. General Pharmacology 1998; 30: 161-166.
6. Massacesi L, Castigii E, Vergelli M, Ollivoto J, Abbamondi AL, Sario F, Amaducci L. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. Journal of Clinical Investigation 1991; 88: 1331-1337.
7. Petkovich M, Brand N, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-445.
8. Mangelsdorf DJ, Ong ES, Dick JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224-225.
9. Goodman DS. Vitamin A and retinoids in health and disease. New England Journal of Medicine 1984; 310: 1023-1031.
10. Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Cancer Research 1983; 43: 3034-3042.
11. Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K. Three novel synthetic retinoids, Re 80, Am 580 and Am-80, all exhibit anti-angiogenic activity in vivo. European Journal of Pharmacology 1993; 249: 113-116.
12. Mangelsdorf DJ, Umesono K, Evans RM. The retinoids: biology, chemistry and medicine. New York: Raven Press Ltd., 1994. pp 319-349.
13. Pfahl M. Nuclear receptor/AP-1 interaction. Endocrine Reviews 1993; 14: 651-658.
14. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Reine CS, McFarlin DE, Scott DE. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. The Journal of Immunology 1995; 154: 450-458.
15. Nagai H, Matsuura S, Bouda K, Takaoka Y, Wang T, Niwa S, Shudo K. Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice. Pharmacology 1999; 58: 101-112.
16. Diab A, Zhu J, Xiao BG, Mustafa M, Link H. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. Journal of Neuropathology and Experimental Neurology 1997; 56: 641-650.
17. Gijbels K, Brocke S, Abrams JS, Steinman L. Administration of neutralizing antibody to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevayed levels of IL-6 bioactivity in central nervous syste, and circulation. Molecular of Medicine 1995; 1: 795-805.
18. Okuda Y, Sakoda S, Bernard CCA, Fujimura H, Saeki Y, Kishimoto T, Yanagihara T IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. International Immunology 1998; 10: 703-708.
19. Kishimoto T The biology of interleukin-6. Blood 1989; 74: 1-15.
20. Hirano T, Akira S, Tada T, KishimotoT Biological and clinical aspect of interleukin-6. Immunology Today 1990; 11: 443-448.
21. Nishimoto N, Yoshizaki K, Eiraku N. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-1 associated myelopathy/tropical spastic paraparesis. Journal of Neurological Science 1990; 97: 183-193.
22. Fre K, Fredrikson S, Fontana A, Link H. Interleukin 6 is elevated in plasma in multiple sclerosis. Journal of Neuroimmunology 1991; 31: 67-74.